secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001193125-24-017311
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics reports preliminary cash of $160.7M; suspends ATM offering
----------------------------------------------------------------------------

- Preliminary unaudited cash, cash equivalents and marketable securities as of Dec 31, 2023: approximately $160.7 million.
- Company suspended and terminated the ATM prospectus effective Jan 29, 2024; no further sales under current Sales Agreement until new prospectus filed.
- Estimate is unaudited and subject to change upon completion of quarter-end and year-end financial close for Q4 and FY2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524017311/0001193125-24-017311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524017311/d88404d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-017311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer